UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1

Clinical trials for UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1 explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1 trials appear

Sign up with your email to follow new studies for UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New hope for slowing advanced neuroendocrine tumors in major trial

Disease control Ongoing

This study is testing if a drug called cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo (inactive pill). It is for about 298 patients whose cancer has continued to grow despite receiving at least one prior standard treatment. The main goal …

Matched conditions: UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1

Get alerted when new UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1 trials appear

New hope for slowing advanced neuroendocrine tumors in major trial